Stock News

25 Most Stressed Cities in the United States
20 Highest Paying Countries for Biotechnology
FDA delays approval deadline for Eli Lilly's Alzheimer's drug
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer's drug
Eli Lilly's Donanemab For Alzheimer's Hits FDA Speed Breaker, Biogen Stock Gains On Delayed Decision
Amylyx’s ALS Drug Fails Trial, Raising Questions About Company’s Future
New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene Therapy
Biogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™) 2024 Annual Meeting
14 Best Beaten Down Stocks To Buy Right Now
Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP
UPDATE 2-EU medicines regulator backs Biogen's ALS drug
20 Most Sustainable Companies in the US

As seen on...